Research expands understanding of vaccine-induced immune thrombocytopenia and thrombosis

FHS
May 16, 2024
7:29 pm

New research led by Flinders University and international experts is expanding understanding of vaccine-induced immune thrombocytopenia and thrombosis (known as VITT).

Surgery improves long-term outcomes for T-OPLL

Thoracic ossification of the posterior longitudinal ligament (TOPLL) is a rare condition associated with ectopic bone formation in the thoracic spine.

August 7, 2024

Jim Wilson secures $100M for global approach aimed at reviving gene therapy field

A gene therapy pioneer thinks he has a solution to the field’s struggle to commercialize breakthrough cures: Go global. Jim Wilson’s Philadelphia-based company GemmaBio on

October 9, 2024

PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023 – Biotech Investments

PharmaSGP Holding SE / Key word(s): Dividend PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023 18-Apr-2024 / 20:31 CET/CEST

April 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.